Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EBS message board posts where the ticker symbol EBS has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest EBS SEC Filings

Filings Format Description Filing Date File/Film Number
10-K  Documents   Interactive Data Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0001367644-18-000014 (34 Act)  Size: 10 MB
2018-02-23 001-33137
18633868
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001367644-18-000011 (34 Act)  Size: 468 KB
2018-02-22 001-33137
18633390
8-K  Documents Current report, items 5.02 and 9.01
Acc-no: 0001367644-18-000008 (34 Act)  Size: 49 KB
2018-02-14 001-33137
18613450
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000932471-18-003501 (34 Act)  Size: 45 KB
2018-02-09 005-82602
18588506
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001258897-18-000908 (34 Act)  Size: 52 KB
2018-02-09 005-82602
18587698
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001140361-18-003133 Size: 10 KB
2018-01-24
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000215457-18-002212 (34 Act)  Size: 13 KB
2018-01-23 005-82602
18541908
8-K  Documents Current report, item 2.02
Acc-no: 0001367644-18-000004 (34 Act)  Size: 17 KB
2018-01-16 001-33137
18527218
8-K  Documents Current report, items 2.02, 7.01, 8.01, and 9.01
Acc-no: 0001367644-18-000002 (34 Act)  Size: 4 MB
2018-01-08 001-33137
18514838
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001140361-18-000849 Size: 9 KB
2018-01-04
More EBS SEC Filings


Related news from
Fri, 23 Feb 2018
15:38:03 +0000
Emergent (EBS) Q4 Earnings Beat Estimates, 2018 View Solid
Emergent's (EBS) earnings and revenues beat estimates in Q4. The top line also improves year over year on higher product sales.
Fri, 23 Feb 2018
10:00:55 +0000
Emergent Biosolutions beats 4Q profit forecasts
The Gaithersburg, Maryland-based company said it had net income of 67 cents per share. Earnings, adjusted for non-recurring costs, were 74 cents per share. The results surpassed Wall Street expectations. ...
Thu, 22 Feb 2018
18:00:00 +0000
Emergent BioSolutions Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 22, 2018 / Emergent BioSolutions Inc. (NYSE: EBS ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 22, 2018, at 5:00 PM Eastern ...
Thu, 22 Feb 2018
14:03:21 +0000
What You Must Know About Emergent BioSolutions Inc’s (NYSE:EBS) 12.20% ROE
Emergent BioSolutions Inc’s (NYSE:EBS) most recent return on equity was a substandard 12.20% relative to its industry performance of 16.59% over the past year. EBS’s results could indicate a relativelyRead More...
Mon, 12 Feb 2018
14:25:00 +0000
Update in Lawsuit for Investors in NYSE: EBS Shares Against Emergent Biosolutions Inc. Announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / February 12, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE: EBS shares against Emergent Biosolutions Inc. over ...
Thu, 08 Feb 2018
13:05:24 +0000
See what the IHS Markit Score report has to say about Emergent Biosolutions Inc.
Emergent Biosolutions Inc NYSE:EBS
Thu, 08 Feb 2018
11:30:00 +0000
Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018
GAITHERSBURG, Md., Feb. 08, 2018-- Emergent BioSolutions Inc. will host a conference call on Thursday, February 22, 2018 at 5:00 pm to discuss the financial results for the fourth quarter and full twelve ...
Tue, 06 Feb 2018
20:21:30 +0000
Here are the D.C.-area stocks getting pummeled in the market rout
Nationally, among the biggest losers as of Monday was Seattle-based radio technology and software maker Impinj Inc. (PI), which saw its stock price plummet 45 percent to $11.94 between Jan. 29 and Feb. 5. The slide follows a stretch that saw U.S. stocks hit historic highs amid investor excitement over strong corporate earnings reports, a growing economy and the passage of a business-friendly tax bill. Last month, the stalwart Dow Jones Industrial Average took just seven days to add 1,000 points and surpass 26,000 for the first time in its history. Gina Martin Adams, chief equity strategist for Bloomberg Intelligence, said investors were overly optimistic in 2017 amid a steady stream of strong corporate earnings reports.
Tue, 06 Feb 2018
15:22:43 +0000
See the D.C.-area stocks hit hardest in the last week
Several D.C.-area publicly traded companies saw their stock prices hit in recent days as U.S. stock exchanges saw a widespread selloff Friday, continuing into Monday trading. In the worst stock market ...
Wed, 31 Jan 2018
13:20:00 +0000
New Research: Key Drivers of Growth for Cavco Industries, National Commerce, The Providence Service, Cisco, Immunomedics, and Emergent Biosolutions — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Jan. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cavco ...
Fri, 19 Jan 2018
15:00:00 +0000
10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
Wed, 10 Jan 2018
13:37:01 +0000
Exact Sciences (EXAS) in Focus: Stock Moves 5.1% Higher
The shares of Exact Sciences (EXAS) rose over 5% yesterday.
Tue, 09 Jan 2018
22:04:10 +0000
Emergent Down on '18 View, Posts Preliminary '17 Results
Emergent (EBS) provides preliminary results for 2017 and its guidance for 2018. The results exceed management's outlook issued in November last year.
Mon, 08 Jan 2018
13:49:01 +0000
The Zacks Analyst Blog Highlights: XOMA, Exelixis, Emergent BioSolutions and Medicines
The Zacks Analyst Blog Highlights: XOMA, Exelixis, Emergent BioSolutions and Medicines
Mon, 08 Jan 2018
11:30:00 +0000
Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook
GAITHERSBURG, Md., Jan. 08, 2018-- Emergent BioSolutions Inc. today announced preliminary unaudited 2017 financial results and guidance for 2018.. Daniel J. Abdun-Nabi, president and chief executive officer ...
Fri, 05 Jan 2018
21:25:09 +0000
4 Biotech Stocks to Watch in the New Year
We take a look at four companies with a favorable Zacks Rank that performed well in 2017 and are likely to continue on the growth path in 2018 as well.
Fri, 05 Jan 2018
14:47:02 +0000
Emergent Starts Phase II Study on Anti-influenza Candidate
Emergent (EBS) initiates a phase II dose-ranging trial to evaluate the safety, pharmacokinetics and clinical benefit of its investigational FLU-IGIV to treat influenza virus infection.
Thu, 04 Jan 2018
12:00:00 +0000
Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection
GAITHERSBURG, Md., Jan. 04, 2018-- Emergent BioSolutions Inc. today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of FLU-IGIV, ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is the place to be to pick up on new and proven investment ideas." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards